A new prescription eye drop could make reading glasses a thing of the past, which would be a game-changer for 128 million Americans. It's hard to imagine a world without glasses, as almost a third of ...

Researchers estimate that about 1.8 billion people around the world live with presbyopia, a farsightedness condition that can appear as a person grows older. More recent treatment options for ...

LENZ Therapeutics is rated HOLD as VIZZ’s commercial potential is highly dependent on uncertain consumer behavior, not medical necessity. LENZ’s current valuation reflects a base-case scenario where ...

There is a new FDA-approved eye drop on the market called Vizz. This once-daily, prescription eye drop is said to help combat presbyopia, otherwise known as age-related blurry vision. Drugmaker LENZ ...